A randomised Australian trial finds breast density notification raises anxiety and confusion and increases GP consultation ...
BIRMINGHAM, AL, UNITED STATES, January 8, 2026 / EINPresswire.com / — Rampart, a Birmingham, Alabama–based medical device ...
Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...
MoonLake regains momentum after the FDA Type B meeting allows BLA submission for sonelokimab in HS without additional trials.
SynuSight Biotech has licensed 18F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment ...
SynuSight Biotech has licensed (18) F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment ...
Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction ...
Breathwork has been shown to help regulate your autonomic nervous system (ANS) through vagal stimulation, and it may also ...
The evidence indicates that non-invasive monitoring (near-infrared spectroscopy; NIRS) of oxygen in brain tissue likely does not reduce death rates or short-term brain problems for very premature ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, announced key milestones achieved in 2025, a year defined by progress, innovation, and growth. Vektor's flagship ...